Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Exempt Offering Notice · D

Lexaria Bioscience Corp.

LEXXNASDAQEQUITYCurrent

Exempt Offering Notice

Filed Sep 21, 2026Accepted Sep 18, 2026, 5:34 PM EDTFiling CIK 1348362Accession 0001348362-26-000002
Share

Structured filing — D

primary_doc.xml

Open full document ↗

Issuer

Name
Lexaria Bioscience Corp.
CIK
0001348362
Entity type
Corporation
Jurisdiction
NEVADA
Phone
250-765-6424
Street
100 - 740 MCCURDY ROAD
City
KELOWNA
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7
Incorporated more than five years ago
true
Previous EDGAR names
LEXARIA CORP. · Lexaria Corp.

Related person 1

First name
Christopher
Last name
Bunka
Relationships
Director
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Related person 2

First name
John
Last name
Docherty
Relationships
Executive Officer · Director
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Related person 3

First name
Richard
Last name
Christopher
Relationships
Executive Officer · Director
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Related person 4

First name
Michael
Last name
Shankman
Relationships
Executive Officer
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Related person 5

First name
Nicholas
Last name
Baxter
Relationships
Director
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Related person 6

First name
William
Middle name
Edward
Last name
McKechnie
Relationships
Director
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Related person 7

First name
ALBERT
Last name
REESE
Relationships
Director
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Related person 8

First name
Bal
Last name
Bhullar
Relationships
Director
Relationship clarification
[blank]
Street
100 - 740 McCurdy Road
City
Kelowna
State / country code
A1
State / country
BRITISH COLUMBIA, CANADA
Postal code
V1X 2P7

Offering

Industry
Biotechnology
Revenue range
$5,000,001 - $25,000,000
Exemption codes
06b
Amendment
false
First sale date
2026-09-09
Offering lasts more than one year
false
Business combination
false
Business combination clarification
[blank]
Minimum investment accepted
0
Total offering amount
113,492
Amount sold
113,492
Remaining amount
0
Amount clarification
Value represents proceeds received from warrants issued. The warrants were issued pursuant to a warrant inducement agreement whereby warrant holders agreed to exercise their warrants at market price and were issued 2x replenishment warrants
Non-accredited investors reported
false
Investors already participating
3

Commissions, fees and proceeds

Sales commissions
7,944
Finders’ fees
0
Commission / fee clarification
Represents 7% of monies received for the warrants issued. Placement agent also received an additional $402,625.10 being 7% of the proceeds received from the exercise of warrants under the warrant inducement agreement
Gross proceeds used
0
Use of proceeds clarification
[blank]

Sales compensation recipient 1

Name
H.C. WAINWRIGHT & CO.
CRD
375
Associated broker-dealer
None
Broker-dealer CRD
None
Foreign solicitation
true
Street
420 Park Avenue
Street (continued)
4th Floor
City
New York
State / country code
NY
State / country
NEW YORK
Postal code
10022
States of solicitation
IL · NY
Solicitation description
ILLINOIS · NEW YORK

Signature authorization

Authorized representative
false

Signature 1

Issuer
Lexaria Bioscience Corp.
Signer
Richard Christopher
Signed
/Richard Christopher/
Title
CEO
Date
2026-09-18

Company context

Lexaria is a biotechnology company dedicated to the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients (“APIs”) using our patented DehydraTECHTM drug delivery technology. DehydraTECH combines APIs with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods.

Current securities

Historical securities (2)

Recent company filings

  1. EFFECT filingOct 13, 2026
  2. 424B3 filingOct 13, 2026
  3. S-3 filingOct 2, 2026
  4. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD DisclosureSep 9, 2026
  5. Other EventsSep 1, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.